★ Sign in to follow
IT

IRLAB Therapeutics Stock: price and insider trades · Sweden

ISIN SE0009242225SE·

No insider purchase over the last 90 days. The latest, by Maria Margareta Linnéa Jalmelid, was filed 12 Sept 2019.

IRLAB Therapeutics: what insiders have been doing

This page follows insider dealings at IRLAB Therapeutics as filed with Finansinspektionen. The past year has been quiet: not a single insider filing for IRLAB Therapeutics. The previous disclosure was published on 12 September 2019.

The full history, which starts in 2017, counts 16 purchases against no sales.

For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
20
Thresholds
n/a
Buy Volume
€418,976
16 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 12 September 2019
Declarations20 total
  • ▲
    Maria Margareta Linnéa Jalmelid
    Chief of Clinical OperationsExecutives
    74,916 SEK31FI-SE
    1,916 shares@ SEK 39.10100.0% of flowAktieISIN SE0012675361FI:csv-8287ac8e4485731dc467
    Canonical exit: 11 Dec 2019 (T+90)
  • ▲
    Viktor Siewertz
    CFOExecutives
    63,560 SEK20FI-SE
    2,000 shares@ SEK 31.7813.1% of flowAktieISIN SE0012675361FI:csv-93aaef5dfbce1b585ed3
    Canonical exit: 4 Dec 2019 (T+90)
  • ▲
    Hans Olov Sören Olsson
    Styrelseledamot/suppleantExecutives
    672,000 SEK22FI-SE
    2,000 shares@ SEK 336.0031.5% of flowAktieISIN SE0009242225FI:csv-46d64430816cbfe21cbc
    Canonical exit: 3 Jan 2019 (T+90)
  • ▲
    John Wakely
    Styrelseledamot/suppleantExecutives
    1M SEK15FI-SE
    4,000 shares@ SEK 349.23100.0% of flowAktieISIN SE0009242225FI:csv-1d12938f0094ce64a33b
    Canonical exit: 23 Dec 2018 (T+90)
  • ▲
    Anders Vedin
    Styrelseledamot/suppleantExecutives
    120,200 SEK11FI-SE
    1,000 shares@ SEK 120.2035.8% of flowISIN SE0009242225FI:csv-3fd98fa61eb652c4d311
    Canonical exit: 12 Jul 2018 (T+90)
  • ▲
    Hans Olov Sören Olsson
    Styrelseledamot/suppleantExecutives
    696,252 SEK22FI-SE
    5,486 shares@ SEK 126.914334.5% of flowISIN SE0009242225FI:csv-109a33ce900fb9e51c72
    Canonical exit: 24 Apr 2018 (T+90)
  • ▲
    Anders Vedin
    Styrelseledamot/suppleantExecutives
    12,241 SEK7FI-SE
    96 shares@ SEK 127.5123.8% of flowISIN SE0009242225FI:csv-6ea2ffe0ebac55a41501
    Canonical exit: 24 Apr 2018 (T+90)
  • ▲
    Anders Vedin
    StyrelseordförandeExecutives
    89,218 SEK10FI-SE
    704 shares@ SEK 126.7328.0% of flowISIN SE0009242225FI:csv-303ec2e9cb654a622331
    Canonical exit: 24 Apr 2018 (T+90)
  • ▲
    Hans Olov Sören Olsson
    StyrelseledamotExecutives
    506,300 SEK22FI-SE
    8,300 shares@ SEK 61.0025.4% of flowISIN SE0009242225FI:csv-66670368ea9d3336e9ea
    Canonical exit: 22 Aug 2017 (T+90)
  • ▲
    Hans Olov Sören Olsson
    StyrelseledamotExecutives
    103,700 SEK20FI-SE
    1,700 shares@ SEK 61.005.2% of flowISIN SE0009242225FI:csv-d509cdbfc15d309e7822
    Canonical exit: 22 Aug 2017 (T+90)
  • ▲
    Hans Olov Sören Olsson
    Styrelseledamot/suppleantExecutives
    67,671 SEK19FI-SE
    1,314 shares@ SEK 51.503.4% of flowISIN SE0009242225FI:csv-a4a1ca62d179620220f9
    Canonical exit: 15 Aug 2017 (T+90)
  • ▲
    Anders Vedin
    Styrelseledamot/suppleantExecutives
    101,800 SEK10FI-SE
    2,000 shares@ SEK 50.9032.3% of flowISIN SE0009242225FI:csv-47b03bb0ed48184ae358
    Canonical exit: 14 Aug 2017 (T+90)
  • ▲
    Viktor Siewertz
    COOExecutives
    72,255 SEK25FI-SE
    1,500 shares@ SEK 48.1716.7% of flowISIN SE0009242225FI:csv-6499cdd1b5b4e3dfdac0
    Canonical exit: 6 Jun 2017 (T+90)
  • ▲
    Hans-Peter Ostler
    Styrelseledamot/suppleantExecutives
    141,600 SEK27FI-SE
    3,000 shares@ SEK 47.20100.0% of flowISIN SE0009242225FI:csv-ff9828ed702856fc0bae
    Canonical exit: 5 Jun 2017 (T+90)
  • ▲
    Viktor Siewertz
    COOExecutives
    10,150 SEK11FI-SE
    200 shares@ SEK 50.752.3% of flowISIN SE0009242225FI:csv-a6ad29d5e367da85148a
    Canonical exit: 5 Jun 2017 (T+90)
  • ▲
    Viktor Siewertz
    COOExecutives
    99,020 SEK13FI-SE
    2,000 shares@ SEK 49.5122.8% of flowISIN SE0009242225FI:csv-7b2d2871a71a5cb80190
    Canonical exit: 4 Jun 2017 (T+90)
  • ●
    Nicholas Waters
    VDExecutives
    49,980 SEK30FI-SE
    833 shares@ SEK 60.00100.0% of flowISIN SE0009242225FI:csv-52bcf228bec18111ffd3
  • ●
    Joakim Tedroff
    CMOExecutives
    102,000 SEK16FI-SE
    1,700 shares@ SEK 60.0049.8% of flowISIN SE0009242225FI:csv-74eff23ea643df398711
  • ●
    Viktor Siewertz
    COOExecutives
    195,180 SEK16FI-SE
    3,253 shares@ SEK 60.0045.1% of flowISIN SE0009242225FI:csv-eb5204fed9504cb0cda3
  • ●
    Joakim Tedroff
    CMOExecutives
    102,000 SEK16FI-SE
    1,700 shares@ SEK 60.0050.2% of flowISIN SE0009242225FI:csv-810b2b9b761185266611

20 of 20 declarations

About IRLAB Therapeutics

IRLAB Therapeutics is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.